Eli Lilly
LLY
$819.36
Share price
0.90%
Change (1 day)
-6.73%
Change (1 year)
Categories
With over 33,000 employees worldwide, production plants in 13 countries and annual sales of over $22 billion worldwide, Eli Lilly and Company is one of the largest pharmaceutical companies in the world. It was founded in Indianapolis in 1876 by the pharmacologist, officer and entrepreneur Eli Lilly.
Market capitalization of Eli Lilly (LLY)
Market cap: $735.56 Billion USD
As of June 2025 Eli Lilly has a market cap of $735.56 Billion USD. This makes Eli Lilly the world's 14th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Eli Lilly from 1996 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | $735.56 B | 4.44% |
| 2024 | $704.31 B | 27.28% |
| 2023 | $553.36 B | 59.19% |
| 2022 | $347.61 B | 31.56% |
| 2021 | $264.22 B | 63.6% |
| 2020 | $161.50 B | 28.34% |
| 2019 | $125.84 B | 2.83% |
| 2018 | $122.38 B | 31.6% |
| 2017 | $92.99 B | 14.54% |
| 2016 | $81.19 B | -12.81% |
| 2015 | $93.12 B | 21.54% |
| 2014 | $76.62 B | 34.53% |
| 2013 | $56.95 B | 0.73% |
| 2012 | $56.54 B | 17.52% |
| 2011 | $48.11 B | 19.17% |
| 2010 | $40.37 B | -1.6% |
| 2009 | $41.03 B | -10.38% |
| 2008 | $45.78 B | -24.4% |
| 2007 | $60.56 B | 2.72% |
| 2006 | $58.95 B | -7.81% |
| 2005 | $63.95 B | -0.44% |
| 2004 | $64.23 B | -18.72% |
| 2003 | $79.03 B | 10.88% |
| 2002 | $71.27 B | -19.21% |
| 2001 | $88.22 B | -15.85% |
| 2000 | $104.84 B | 44.61% |
| 1999 | $72.50 B | -25.6% |
| 1998 | $97.44 B | 26.03% |
| 1997 | $77.32 B | 90.29% |
| 1996 | $40.63 B |
End of Day market cap according to different sources
On Jun 14th, 2025 the market cap of Eli Lilly was reported to be:
$776.53 Billion USD
$735.56 Billion USD
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Bristol-Myers Squibb BMY | $101.24 B | -86.24% | 🇺🇸 USA |
 Merck MRK | $205.17 B | -72.11% | 🇺🇸 USA |
 Johnson & Johnson JNJ | $377.99 B | -48.61% | 🇺🇸 USA |
 Pfizer PFE | $139.51 B | -81.03% | 🇺🇸 USA |
 Sanofi SNY | $120.94 B | -83.56% | 🇫🇷 France |
 GlaxoSmithKline GSK | $82.77 B | -88.75% | 🇬🇧 UK |
 AbbVie ABBV | $337.52 B | -54.11% | 🇺🇸 USA |
 Amgen AMGN | $158.74 B | -78.42% | 🇺🇸 USA |
 Novartis NVS | $235.92 B | -67.93% | 🇨🇭 Switzerland |
 AstraZeneca AZN | $230.73 B | -68.63% | 🇬🇧 UK |